共 50 条
- [31] The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials British Journal of Cancer, 2007, 97 : 577 - 581
- [36] Phase 0 trials/ Intra-Target-Microdosing (ITM) and the lung: a review BMC PULMONARY MEDICINE, 2024, 24 (01):
- [37] Phase 0 clinical trials: theoretical and practical implications in oncologic drug development OPEN ACCESS JOURNAL OF CLINICAL TRIALS, 2013, 5 : 119 - 126
- [38] Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2016, 9 (02): : 74 - 88